Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ER/HER2 early breast cancer

Immunological Aspects of Malignant Gliomas

NK Cell Activation in the Antitumor Response Induced by IFN-α Dendritic Cells Loaded with Apoptotic Cells from Follicular Lymphoma Patients

HSP70L1-mediated intracellular priming of dendritic cell vaccination induces more potent CTL response against cancer

Dendritic cell vaccination in melanoma patients: From promising results to future perspectives

Anti-tumor efficacy of the Runx2-dendritic cell vaccine in triple-negative breast cancer in vitro.

Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination

Progress of dendritic cell-based cancer vaccines for patients with hematological malignancies

Dendritic cells-based vaccine to inhibit triple-negative breast cancer cells proliferation.

Safety and initial clinical efficacy of a dendritic cell (DC) vaccine in locally advanced, triple-negative breast cancer (TNBC) patients (pts).